A detailed history of Armistice Capital, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 5,200,000 shares of VYGR stock, worth $29.8 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
5,200,000
Previous 5,200,000 -0.0%
Holding current value
$29.8 Million
Previous $41.1 Million 26.04%
% of portfolio
0.5%
Previous 0.54%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.42 - $10.54 $3.92 Million - $5.57 Million
528,000 Added 11.3%
5,200,000 $41.1 Million
Q1 2024

May 15, 2024

BUY
$7.15 - $10.84 $3.12 Million - $4.73 Million
436,000 Added 10.29%
4,672,000 $43.5 Million
Q4 2023

Feb 13, 2024

BUY
$6.28 - $8.81 $364,240 - $510,980
58,000 Added 1.39%
4,236,000 $35.8 Million
Q3 2023

Nov 14, 2023

BUY
$7.55 - $11.25 $4.18 Million - $6.23 Million
554,000 Added 15.29%
4,178,000 $32.4 Million
Q2 2023

Aug 14, 2023

BUY
$6.94 - $13.99 $694,000 - $1.4 Million
100,000 Added 2.84%
3,624,000 $41.5 Million
Q1 2023

May 15, 2023

BUY
$6.0 - $10.78 $768,000 - $1.38 Million
128,000 Added 3.77%
3,524,000 $27.2 Million
Q3 2022

Nov 14, 2022

BUY
$5.57 - $7.47 $4.63 Million - $6.22 Million
832,000 Added 32.45%
3,396,000 $20.1 Million
Q2 2022

Aug 15, 2022

BUY
$4.82 - $10.09 $2.72 Million - $5.69 Million
564,000 Added 28.2%
2,564,000 $15.2 Million
Q1 2022

May 16, 2022

BUY
$2.75 - $9.44 $5.5 Million - $18.9 Million
2,000,000 New
2,000,000 $15.2 Million
Q4 2021

Feb 14, 2022

SELL
$2.47 - $5.55 $9.18 Million - $20.6 Million
-3,716,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$4.61 - $9.04 $1.49 Million - $2.93 Million
324,000 Added 9.55%
3,716,000 $17.5 Million
Q4 2020

Feb 16, 2021

BUY
$7.15 - $12.28 $4.95 Million - $8.5 Million
692,000 Added 25.63%
3,392,000 $24.3 Million
Q3 2020

Nov 16, 2020

BUY
$10.01 - $13.75 $6.23 Million - $8.55 Million
622,000 Added 29.93%
2,700,000 $28.8 Million
Q2 2020

Aug 14, 2020

SELL
$8.05 - $14.21 $1.27 Million - $2.25 Million
-158,000 Reduced 7.07%
2,078,000 $26.2 Million
Q1 2020

May 15, 2020

BUY
$6.8 - $14.66 $4.16 Million - $8.97 Million
612,000 Added 37.68%
2,236,000 $20.5 Million
Q4 2019

Feb 14, 2020

BUY
$12.82 - $16.85 $6.77 Million - $8.9 Million
528,000 Added 48.18%
1,624,000 $22.7 Million
Q3 2019

Nov 14, 2019

BUY
$16.31 - $28.29 $2.61 Million - $4.53 Million
160,000 Added 17.09%
1,096,000 $18.9 Million
Q2 2019

Aug 14, 2019

SELL
$19.18 - $27.88 $11.5 Million - $16.7 Million
-600,000 Reduced 39.06%
936,000 $25.5 Million
Q1 2019

May 15, 2019

SELL
$8.0 - $19.66 $10.4 Million - $25.6 Million
-1,300,000 Reduced 45.84%
1,536,000 $29.4 Million
Q4 2018

Feb 14, 2019

BUY
$8.59 - $18.05 $9.55 Million - $20.1 Million
1,112,000 Added 64.5%
2,836,000 $26.7 Million
Q3 2018

Nov 14, 2018

BUY
$17.11 - $21.74 $22.1 Million - $28.1 Million
1,292,000 Added 299.07%
1,724,000 $32.6 Million
Q2 2018

Aug 14, 2018

BUY
$16.76 - $23.92 $7.24 Million - $10.3 Million
432,000 New
432,000 $8.44 Million

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $221M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.